dynorphin (1-8) has been researched along with phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide in 2 studies
Studies (dynorphin (1-8)) | Trials (dynorphin (1-8)) | Recent Studies (post-2010) (dynorphin (1-8)) | Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) |
---|---|---|---|---|---|
173 | 0 | 3 | 276 | 0 | 55 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadet, JL; Emilien, B; Goodman, CB; Heyliger, S; Lee, CH; Partilla, JS; Rothman, RB; Yang, HY | 1 |
Ballet, S; Bourgoin, S; Braz, J; Cesselin, F; Hamon, M; Mauborgne, A; Zajac, JM | 1 |
2 other study(ies) available for dynorphin (1-8) and phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
Article | Year |
---|---|
Chronic exposure to antibodies directed against anti-opiate peptides alter delta-opioid receptor levels.
Topics: alpha-MSH; Animals; Antibodies; Autoradiography; Brain; Dynorphins; Male; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Opioid-Related Disorders; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tissue Distribution | 1999 |
The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord.
Topics: Animals; Dose-Response Relationship, Drug; Dynorphins; Injections, Spinal; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Oligopeptides; Peptide Fragments; Perfusion; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Spinal Cord | 2002 |